Clinical Strategies for Cancer Treatment: The Role of Drugs Preclinical Aspects of Cancer Drug Discovery and Development Pharmacokinetics and Clinical Monitoring Infertility after Cancer Chemotherapy Carcinogenesis: A Late Complication of Cancer Chemotherapy Steroid Hormone Therapies for Cancer Antifolates 5-Fluoropyrimidines Cytidine Analogs Purine Antimetabolites Hydroxyurea Antimicrotubule Agents Alkylating Agents Nonclassic Alkylating Agents Cisplatin and Analogs Bleomycin Antitumor Antibiotics Anthracyclines and Anthracenediones Topoisomerase II Inhibitors: Epipodophyllotoxins, Acridines, Ellipticines, and Bisdioxopiperazines Topoisomerase I Targeting Agents: The Camptothecins Enzyme Therapy: l-Asparaginase Pharmacologic Considerations in Chemotherapy for Brain Tumors Retinoids and Other Differentiating Agents Bisphosphonates Radiation Modifiers Pharmacology of Interferons:Induced Proteins, Cell Activation, and Antitumor Activity Clinical Pharmacokinetics of Interleukin 1, Interleukin 2, Interleukin 4, Tumor Necrosis Factor, Interleukin 12, and Macrophage Colony-Stimulating Factor Colony-Stimulating Factors Antibody-Based Immunotherapies for Cancer Targeted Therapy Physical Barriers to Drug Delivery Adoptive Cellular Therapy Cancer Vaccines Cytokine and Growth Factor and Receptor Database: Biologic, Molecular, and Pathophysiologic Properties of Ligand-Receptor Interactions Inhibitors of Tumor Angiogenesis Pharmacogenetics Chemokine-Chemokine Receptor Database 2001: Biologic, Molecular, and Pathophysiologic Properties of Chemokine-Receptor Interactions Index.